G. Fernández-Hinojal

PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity

María Gato, Miren Zuazo, Hugo Arasanz et al. · Cell Reports · 2017 · 314 citations · Full text

Apoptosis, Immunology, Cell Death +19

Functional systemic <scp>CD</scp> 4 immunity is required for clinical responses to <scp>PD</scp> ‐L1/ <scp>PD</scp> ‐1 blockade therapy

Miren Zuazo, Hugo Arasanz, G. Fernández-Hinojal et al. · EMBO Molecular Medicine · 2019 · 211 citations · Full text

PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer

Ana Bocanegra, G. Fernández-Hinojal, Miren Zuazo-Ibarra et al. · International Journal of Molecular Sciences · 2019 · 73 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Pd-l1 Expression +15

Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer

Hugo Arasanz, Ana Bocanegra, Idoia Morilla et al. · Cancers · 2022 · 35 citations · Full text

Cancer Immunosurveillance, Baseline Ldns, Medicine +14

Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy

Miren Zuazo, Hugo Arasanz, M.J. García Granda et al. · Annals of Oncology · 2019 · 33 citations · Full text

Clinical Immunology, Cancer Immunosurveillance, Autoimmune Disease +10